News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
9 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
2 (186)
3 (175)
4 (147)
5 (166)
6 (119)
9 (121)
10 (183)
11 (172)
12 (142)
13 (112)
14 (38)
15 (1)
16 (171)
17 (154)
18 (148)
19 (149)
20 (92)
21 (2)
23 (153)
24 (148)
25 (216)
26 (204)
27 (119)
28 (2)
29 (9)
30 (193)
31 (218)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
9
10
11
12
13
14
15
16
17
18
19
20
21
23
24
25
26
27
28
29
30
31
Drug Development
Pfizer Release: One Year Maintenance and Switching Data in Patients with Crohn’s Disease Support the Use of INFLECTRA (infliximab CT-P13) in IBD1
Pfizer and Celltrion Healthcare jointly announced the secondary outcomes from the phase III trial of INFLECTRA in CD at the 25th United European Gastroenterology Week.
October 29, 2017
·
16 min read
BioMidwest
Esanex Presents New Data on SNX-5422 Anti-Tumor Activity Alone and in Combination with Checkpoint Inhibitors at 2017 AACR-NCI-EORTC Meeting
Esanex, Inc. announced that it is presenting preclinical data from its Heat Shock Protein 90 (Hsp90) inhibitor SNX-5422 program, showing promising anti-tumor effects both alone and in combination with checkpoint inhibitors,
October 29, 2017
·
2 min read
BioForest
Inscope Medical Solutions Launches First Laryngoscope with Integrated Suction
The Inscope Direct is a disposable laryngoscope that allows clinicians to maintain a clear view of the airway.
October 29, 2017
·
3 min read
Biotech Bay
Millipede Announces Peer Reviewed Publications
Millipede today announced the release of two peer-reviewed publications describing the use and efficacy of the transcatheter Millipede IRIS mitral annuloplasty ring.
October 29, 2017
·
1 min read
Drug Development
Rgenix Reports Preliminary Phase Ia/b Clinical Data Demonstrating Immune-stimulatory Activity with RGX-104 in Advanced Cancer Patients
These data demonstrate immune-stimulatory activity in solid tumor patients with highly-refractory malignancies, including patients who have failed prior checkpoint inhibitors.
October 29, 2017
·
5 min read
Drug Development
Data on the Preventive Effects of HAEGARDA in Subjects With Very Frequent HAE Attacks Presented by CSL Behring at the 2017 ACAAI Annual Scientific Meeting
CSL Behring today presented data indicating that, at the approved dose of 60 IU/kg, HAEGARDA reduced the median number of HAE attacks per month by 98 percent in subjects who had frequent attacks, from a 16-week placebo period to a 16-week treatment period.
October 29, 2017
·
6 min read
Rapid DNA Testing by Atlanta’s AABB Accredited Relationship (DNA) Testing Laboratory, IntelliGenetics
IntelliGenetics is now offering same-day results Court/Legal DNA Paternity Tests.
October 29, 2017
·
2 min read
Biotech Bay
ReCor Medical Announces 1000th Enrollment and 150th Randomization in RADIANCE-HTN Hypertension Study
ReCor Medical announced progress milestones in the study of its Paradise Renal Denervation System as a potential treatment for hypertension, including the 1000th consented and the 150th randomized subjects in the RADIANCE-HTN study, and publication of a study design review in the American Heart Journal.
October 29, 2017
·
3 min read
Early-Stage Medtech HighLife Nabs $14M for Transcatheter Mitral Valve Replacement
The cash allows for the acceleration of the company’s clinical and R&D program.
October 29, 2017
·
3 min read